|
Market Closed -
Hong Kong S.E.
07:08:29 20/11/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 16.39 HKD | -5.53% |
|
-19.02% | +20.07% |
| 14/11 | Zai Lab Limited - Special Call | |
| 13/11 | Zai Lab Says Experimental Drug Reduced Activity of Protein Linked to Atopic Dermatitis by at Least 90% | MT |
Company Valuation: Zai Lab Limited
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 6,059 | 2,946 | 2,688 | 2,853 | 1,962 | 2,365 | - | - |
| Change | - | -51.37% | -8.77% | 6.15% | -31.23% | 20.53% | - | - |
| Enterprise Value (EV) 1 | 4,650 | 1,938 | 1,897 | 2,095 | 1,397 | 1,726 | 1,891 | 2,045 |
| Change | - | -58.33% | -2.13% | 10.47% | -33.34% | 23.59% | 9.55% | 8.15% |
| P/E | -8.29x | -6.63x | -7.9x | -10.1x | -11x | -12.3x | -10.1x | -18.4x |
| PBR | 4.35x | - | 3.34x | 3.36x | 2.73x | 3.04x | 5.04x | 4.58x |
| PEG | - | 0.2x | 0.3x | 0.4x | 0.3x | -1.73x | -0.5x | 0.4x |
| Capitalization / Revenue | 42x | 13.7x | 10.1x | 7.15x | 4.26x | 5.39x | 4.4x | 3.33x |
| EV / Revenue | 32.2x | 9.01x | 7.11x | 5.25x | 3.04x | 3.93x | 3.52x | 2.88x |
| EV / EBITDA | -6.7x | -4.89x | -5.3x | -7.75x | -6.51x | -6.45x | -7.98x | -11.9x |
| EV / EBIT | -6.64x | -4.79x | -5.17x | -7.43x | -6.09x | -6.84x | -8.16x | -11x |
| EV / FCF | -8.19x | -4.94x | -9.23x | -9.5x | -8.5x | -9.44x | -11.3x | -18.1x |
| FCF Yield | -12.2% | -20.2% | -10.8% | -10.5% | -11.8% | -10.6% | -8.86% | -5.53% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -7.58 | -4.63 | -3.46 | -2.6 | -1.6 | -1.714 | -2.087 | -1.141 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 144.3 | 215 | 266.7 | 399 | 460.2 | 439 | 537.6 | 710.3 |
| EBITDA 1 | -693.6 | -396.1 | -357.5 | -270.3 | -214.4 | -267.8 | -236.9 | -171.5 |
| EBIT 1 | -700.1 | -404.4 | -366.6 | -282.1 | -229.4 | -252.3 | -231.7 | -185.1 |
| Net income 1 | -704.5 | -443.3 | -334.6 | -257.1 | -175.5 | -204.9 | -218.2 | -147 |
| Net Debt 1 | -1,409 | -1,008 | -791.3 | -757.9 | -565.3 | -638.7 | -473.9 | -319.7 |
| Reference price 2 | 62.85 | 30.70 | 27.33 | 26.19 | 17.64 | 21.03 | 21.03 | 21.03 |
| Nbr of stocks (in thousands) | 96,409 | 95,972 | 98,349 | 108,937 | 111,219 | 112,445 | - | - |
| Announcement Date | 2/3/22 | 2/3/23 | 28/2/24 | 27/2/25 | 26/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 39.41x | 13.36x | 28.32x | 0.51% | 1,200B | ||
| 36.94x | 6.65x | 18.71x | 1.97% | 651B | ||
| 36.49x | 8.39x | 17.36x | 2.41% | 506B | ||
| 21.41x | 5.17x | 12.95x | 2.53% | 377B | ||
| 94.91x | 5.47x | 23.3x | 2.54% | 330B | ||
| 22.98x | 5.56x | 13.52x | 2.87% | 288B | ||
| 23.04x | 4.63x | 13.15x | 1.9% | 272B | ||
| 22.49x | 6.97x | 12.81x | 2.32% | 236B | ||
| -39.14x | 7.25x | 45.66x | 1.98% | 206B | ||
| Average | 28.72x | 7.05x | 20.64x | 2.11% | 452B | |
| Weighted average by Cap. | 34.25x | 8.45x | 21.50x | 1.77% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ZLAB Stock
- 9688 Stock
- Valuation Zai Lab Limited
Select your edition
All financial news and data tailored to specific country editions
















